| On the definition and the computation of the basic reproduction ratio R 0 in models for infectious diseases in heterogeneous populations | journal | June 1990 | 
    | On a new perspective of the basic reproduction number in heterogeneous environments | journal | August 2011 | 
    | Mass concentration in a nonlocal model of clonal selection | journal | March 2016 | 
    | Adaptation to Stochastic Temporal Variations in Intratumoral Blood Flow: The Warburg Effect as a Bet Hedging Strategy | journal | May 2017 | 
    | Micropharmacology: An In Silico Approach for Assessing Drug Efficacy Within a Tumor Tissue | journal | February 2018 | 
    | Characterizing Chemotherapy-Induced Neutropenia and Monocytopenia Through Mathematical Modelling | journal | July 2020 | 
    | Persister cells and tolerance to antimicrobials | journal | January 2004 | 
    | Cell population heterogeneity and evolution towards drug resistance in cancer: Biological and mathematical assessment, theoretical treatment optimisation | journal | November 2016 | 
    | Tumor heterogeneity: Causes and consequences | journal | January 2010 | 
    | A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations | journal | April 2010 | 
    | Stochastic State Transitions Give Rise to Phenotypic Equilibrium in Populations of Cancer Cells | journal | August 2011 | 
    | Memory Sequencing Reveals Heritable Single-Cell Gene Expression Programs Associated with Distinct Cellular Behaviors | journal | August 2020 | 
    | Endogenous Replication Stress in Mother Cells Leads to Quiescence of Daughter Cells | journal | May 2017 | 
    | Prolonged Prometaphase Blocks Daughter Cell Proliferation Despite Normal Completion of Mitosis | journal | September 2010 | 
    | Bet-hedging in stochastically switching environments | journal | November 2013 | 
    | Understanding the role of phenotypic switching in cancer drug resistance | journal | April 2020 | 
    | Toward understanding of the role of reversibility of phenotypic switching in the evolution of resistance to therapy | journal | June 2018 | 
    | The evolution of bet-hedging adaptations to rare scenarios | journal | December 2007 | 
    | Non-genetic cancer cell plasticity and therapy-induced stemness in tumour relapse: ‘What does not kill me strengthens me’ | journal | May 2015 | 
    | Dynamics of multiple myeloma tumor therapy with a recombinant measles virus | journal | June 2009 | 
    | Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance | journal | June 2017 | 
    | Competing memories of mitogen and p53 signalling control cell-cycle entry | journal | September 2017 | 
    | Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells | journal | February 2016 | 
    | Non-Darwinian dynamics in therapy-induced cancer drug resistance | journal | September 2013 | 
    | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition | journal | February 2015 | 
    | Understanding and targeting resistance mechanisms in NSCLC | journal | October 2017 | 
    | Cancer drug resistance: an evolving paradigm | journal | September 2013 | 
    | Turning ecology and evolution against cancer | journal | April 2014 | 
    | The mathematics of cancer: integrating quantitative models | journal | November 2015 | 
    | Tumour heterogeneity and resistance to cancer therapies | journal | November 2017 | 
    | Persister cells, dormancy and infectious disease | journal | December 2006 | 
    | Spatial competition constrains resistance to targeted cancer therapy | journal | December 2017 | 
    | Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer | journal | November 2017 | 
    | Age structure landscapes emerge from the equilibrium between aging and rejuvenation in bacterial populations | journal | September 2018 | 
    | Hidden heterogeneity and circadian-controlled cell fate inferred from single cell lineages | journal | December 2018 | 
    | Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures | journal | May 2020 | 
    | Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer | journal | February 2019 | 
    | Cooperation among cancer cells: applying game theory to cancer | journal | November 2018 | 
    | Rapid phenotypic individualization of bacterial sister cells | journal | August 2017 | 
    | Neighborhood size-effects shape growing population dynamics in evolutionary public goods games | journal | February 2019 | 
    | Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells | journal | September 2009 | 
    | The Cell Cycle Switch Computes Approximate Majority | journal | September 2012 | 
    | Single-cell analysis resolves the cell state transition and signaling dynamics associated with melanoma drug-induced resistance | journal | December 2017 | 
    | Evolution of intratumoral phenotypic heterogeneity: the role of trait inheritance | journal | August 2013 | 
    | Model genotype–phenotype mappings and the algorithmic structure of evolution | journal | November 2019 | 
    | Genotype–phenotype mapping and the end of the ‘genes as blueprint’ metaphor | journal | February 2010 | 
    | Global microRNA depletion suppresses tumor angiogenesis | journal | May 2014 | 
    | Density Dependence and Cooperation: Theory and a test with Bacteria | journal | September 2009 | 
    | Bacterial Persistence as a Phenotypic Switch | journal | September 2004 | 
    | Mechanisms of bacterial persistence during stress and antibiotic exposure | journal | December 2016 | 
    | Temporal integration of mitogen history in mother cells controls proliferation of daughter cells | journal | April 2020 | 
    | Adaptive Therapy | journal | June 2009 | 
    | Impact of Metabolic Heterogeneity on Tumor Growth, Invasion, and Treatment Outcomes | journal | April 2015 | 
    | Emergence of Drug Tolerance in Cancer Cell Populations: An Evolutionary Outcome of Selection, Nongenetic Instability, and Stress-Induced Adaptation | journal | January 2015 | 
    | Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer Therapies | journal | January 2018 | 
    | Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel | journal | March 2004 | 
    | Evolutionary Determinants of Cancer | journal | July 2015 | 
    | Morphisms of reaction networks that couple structure to function | journal | January 2014 | 
    | Tracking the evolution of cancer cell populations through the mathematical lens of phenotype-structured equations | journal | August 2016 | 
    | Bistability in a Metabolic Network Underpins the De Novo Evolution of Colony Switching in Pseudomonas fluorescens | journal | March 2015 | 
    | Spontaneously slow-cycling subpopulations of human cells originate from activation of stress-response pathways | journal | March 2019 | 
    | Competing evolutionary paths in growing populations with applications to multidrug resistance | journal | April 2019 | 
    | Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer | journal | August 2019 | 
    | Stochasticity in the Genotype-Phenotype Map: Implications for the Robustness and Persistence of Bet-Hedging | journal | December 2016 | 
    | Cancer statistics, 2018: Cancer Statistics, 2018 | journal | January 2018 | 
    | Equivalences between age structured models and state dependent distributed delay differential equations | journal | January 2019 |